The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Interim analysis and biomarker data from a multicenter study (LCMC3).
 
David J. Kwiatkowski
Consulting or Advisory Role - Genentech/Roche; Novartis
Research Funding - AADi; Genentech/Roche; Revolution Medicines
 
Valerie W. Rusch
Research Funding - Genelux (Inst); Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; da Vinci Surgery
Other Relationship - NIH/Coordinating Center for Clinical Trials
 
Jamie E. Chaft
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Merck
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)
 
Bruce E. Johnson
Research Funding - Novartis (Inst); Novartis (Inst); Novartis (Inst); Toshiba (Inst)
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute
 
Alan Nicholas
Employment - Genentech; Mallinckrodt
Stock and Other Ownership Interests - Roche/Genentech
Travel, Accommodations, Expenses - Genentech
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - AstraZeneca/MedImmune; Asuragen; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Guardant Health; HTG Molecular Diagnostics; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; MSD Oncology; Pfizer; Roche
Research Funding - 4D Molecular Therapeutics (Inst); Adaptimmune (Inst); Amgen (Inst); Bayer (Inst); EMD Serono (Inst); Genentech (Inst); Guardant Health (Inst); HTG Molecular Diagnostics (Inst); Karus Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); OncoPlex Diagnostics (Inst); Pfizer (Inst); Silicon Biosytems (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; GlaxoSmithKline; Guardant Health; HTG Molecular Diagnostics; MSD Oncology; Pfizer
 
Robert Merritt
Honoraria - Intuitive Surgical
Speakers' Bureau - Intuitive Surgical
 
Jay M. Lee
Consulting or Advisory Role - Genentech/Roche
Research Funding - Genentech/Roche; Merck
Travel, Accommodations, Expenses - Genentech/Roche
 
Paul A. Bunn
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; Merck Serono
Research Funding - Genentech (Inst)
 
Yan Tang
No Relationships to Disclose
 
See-Chun Phan
Employment - Genentech; Syapse (I)
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Use of Avastin for the treatment of metastatic breast cancer (Inst)
Travel, Accommodations, Expenses - Genentech
 
Saiama Naheed Waqar
Research Funding - ARIAD (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Checkpoint Therapeutics (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Hengrui Therapeutics (Inst); Ignyta (Inst); Lilly (Inst); Merck (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst); Spectrum Pharmaceuticals (Inst); Stem CentRx (Inst); Synermore biologics (Inst); Vertex (Inst); Xcovery (Inst)
 
Alexander Patterson
No Relationships to Disclose
 
Eric B. Haura
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen Oncology
Research Funding - Boehringer Ingelheim; FORMA Therapeutics; Ignyta; Janssen; Lilly
Patents, Royalties, Other Intellectual Property - Patent pending on PLA technology related to kinase inhibitor sensitivity biomarkers
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Eric M. Toloza
Speakers' Bureau - Biodesix
 
Karen L. Reckamp
Consulting or Advisory Role - Amgen; ARIAD; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Euclises; Exelixis; Guardant Health; Loxo; Precision Health Economics; Seagen; Takeda; Tesaro
Research Funding - Abbvie (Inst); ACEA Biosciences (Inst); Adaptimmune (Inst); ARIAD (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Guardant Health (Inst); Janssen Oncology (Inst); Loxo (Inst); Molecular Partners (Inst); Pfizer (Inst); Seagen (Inst); Xcovery (Inst); Zeno Pharmaceuticals (Inst)
 
Dan Raz
Research Funding - Merck
 
Katja Schulze
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Ann Johnson
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
David Paul Carbone
Employment - James Cancer Center
Honoraria - AstraZeneca; Nexus Pharmaceuticals Inc
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Biothera; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Genentech/Roche; Helsinn Therapeutics; Incyte; Inivata; Loxo; Merck; Novartis; Peregrine Pharmaceuticals; Pfizer; Synta; Synta
Research Funding - Bristol-Myers Squibb